Hikma launches Neostigmine Methylsulfate injection
Neostigmine Methylsulfate injection is indicated for the reversal of the effects of nondepolarizing neuromuscular blocking agents after surgery.
Hikma has launched Neostigmine Methylsulfate injection in prefilled syringe form.
The 3 mg/3 ml PFS is a cholinesterase inhibitor.
[Read more: Hikma to acquire Custopharm]
It is indicated for reversal of the effects of nondepolarizing neuromuscular blocking agents after surgery.